Biktarvy 50-200-25 MG tablet UU 30S
Ended Awarded
- Contract number
- SPE2DB26FQ72K
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $13,502
Award facts
- Contract value 100% obligated
- $13,501.58 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $13,501.58 delivery order to AmerisourceBergen Drug Corp for BIKTARVY 50-200-25 mg tablets (30-count unit doses) on October 23, 2025, with an ultimate completion date of October 24, 2025. This is a firm fixed price, competitively awarded delivery order with no set-aside designation, fulfilling pharmaceutical supply requirements for federal military and healthcare systems. The product will be delivered to AmerisourceBergen's place of performance in Conshohocken, Pennsylvania, where the company maintains its corporate headquarters and primary distribution operations.
This delivery order is a child contract under AmerisourceBergen's Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The IDC serves as a comprehensive global pharmaceutical support vehicle enabling AmerisourceBergen to supply a broad range of pharmaceutical products and medical supplies to military healthcare programs worldwide, including medications, vaccines, syringes, vials, and specialized medical commodities. AmerisourceBergen's position as a major pharmaceutical distributor and critical federal medical procurement vendor is reflected in its consistent receipt of competitively awarded contracts across multiple therapeutic domains, supporting the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems.
Quick answers
Who was awarded contract SPE2DB26FQ72K?
SPE2DB26FQ72K was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on October 23, 2025.
How much is contract SPE2DB26FQ72K worth?
The government has obligated $13,502 on SPE2DB26FQ72K.
Is contract SPE2DB26FQ72K an order under another contract?
Yes. SPE2DB26FQ72K is a delivery order under SPE2DB22D3004, an indefinite delivery contract.
Was contract SPE2DB26FQ72K competed?
The extent of competition for SPE2DB26FQ72K was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award